Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2016 FY- Text added to 2017 FY
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. sophomore Avg
|
New words:
accrual, Adcira, AEs, ALS, ambrisentan, amyotrophic, antisense, assimilation, attendant, auditor, Bioverativ, BMPRII, bosentan, brachii, callable, carryforward, characteristic, clarity, CMT, Congressional, constricted, constriction, content, coordinate, CRISPR, cyclase, cylase, deciliter, dedicated, degradation, effusion, endothelin, epoprostenol, ERA, Erie, fat, fit, fraudulent, fundamental, fundamentally, gait, Gilead, goodwill, gram, guanylate, Hb, heritable, hydroxylase, idiopathic, iloprost, immunomodulatory, inconsistent, indeterminate, inflammation, infusion, inhalation, inherited, intangible, intramuscular, IRC, isolated, Jakafi, karen, Kumar, landscape, largest, LentiGlobin, macitentan, magnetic, managerial, map, media, mid, milligram, misjudgment, MIT, molecular, mucosal, neurologic, nitric, Opsumit, Orenitram, overgrowth, oxide, PAH, PCAOB, PDUFA, penalty, people, pertinent, Pharnext, phosphodiesterase, platelet, pleotherapy, pleural, plexiform, post, presence, prioritized, prolyl, Prostacyclin, provisional, PSU, punishable, quantity, Ravindra, rectify, relax, relaxation, remodeling, Remodulin, resonance, retention, Revatio, riociguat, roxadustat, scenario, selexipag, sGC, sildenafil, smith, smooth, sublessee, swelling, symptomatic, tadalafil, tech, thrombocythemia, Tracleer, transparency, trepostinil, Trevogrumab, tripping, Trump, Tyvaso, understood, uneven, unilateral, Uptravi, vasodilation, vasodilator, Veletri, vera, Vertex, willingly
Removed:
accrue, activated, aggregating, Amgen, annum, answered, Aranesp, arranging, assay, Avastin, axitinib, Beth, bevacizumab, BIDMC, Biogen, birth, breakdown, built, carcinoma, characterization, chemotherapy, clear, closed, colorectal, comparability, complaint, complied, contended, County, creation, cytotoxic, DART, deletion, demonstrating, denied, dexamethasone, differentiated, dismissed, District, dominant, drawn, dyspnea, Electric, endoglin, endometrial, enlarged, exemption, explore, fact, federally, financed, fluid, fourth, glioblastoma, hand, harbor, head, hearing, hematocrit, hepatocellular, HTB, Idec, Importantly, improved, induce, Inlyta, interpreted, invalidity, invented, investigated, invoice, Island, Jewish, journal, Kettering, kidney, knopf, labeled, leasing, led, LICR, lien, loan, LTB, Ludwig, medicine, MedImmune, Memorial, mentioned, mice, motion, moved, narrowly, neck, Nexavar, OncoMed, ordering, ovarian, overexpressed, pancreatic, pazopanib, PCT, PFS, placement, protecting, qualify, ratio, reached, recommending, reimbursable, renal, repaid, repay, repayment, restored, revise, role, sample, sarcoma, scheduling, secured, shared, sharing, Shore, showed, Sloan, soft, solid, sorafenib, spleen, sponsorship, statistically, statute, steel, stipulation, subgroup, Suffolk, sunitinib, Sutent, synergistic, Tracon, tumor, tyrosine, uncontrolled, underexplored, unexercised, VEGF, version, vessel, Votrient, wholly, willfully
Valuein 2016 FY filing- Value in 2017 FY filing
Original filings
Filing view